Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib
Author:
Affiliation:
1. Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain
Publisher
Informa UK Limited
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2024.2304630
Reference10 articles.
1. Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
2. Assessment of alopecia areata universalis successfully treated with upadacitinib
3. Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
4. Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: a case report;Johnston LA;SAGE Open Med Case Rep,2023
5. Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis;Uchida H;J Dermatol,2023
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug-Induced Alopecia Areata From Upadacitinib;Cureus;2024-08-11
2. Multiple drugs;Reactions Weekly;2024-03-16
3. Alopecia areata treatment with baricitinib: different relapse phenotypes;Journal of Dermatological Treatment;2024-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3